SciELO - Scientific Electronic Library Online

 
vol.39 issue2Treatment of Pompe DiseasePompe disease rehabilitation management author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Acta Neurológica Colombiana

Print version ISSN 0120-8748On-line version ISSN 2422-4022

Abstract

MILLAN-PEREZ, Sonia Patricia et al. Pompe's disease: History, epidemiology, pathophysiology and clinical manifestations. Acta Neurol Colomb. [online]. 2023, vol.39, n.2, e5.  Epub Nov 02, 2023. ISSN 0120-8748.  https://doi.org/10.22379/anc.v39i2.1752.

Introduction:

Pompe's disease or glucogenosis type II belongs to the group of metabolic myopathies and is caused by a partial or total deficiency of the acid alpha glucosidase enzyme. The lack/deficiency of this enzyme generates glycogen storage inside the lysosomes in various tissues including skeletal muscle, myocardium and smooth muscle cells. It is a multisystemic disease that can have an early onset or a late onset.

Contents:

In this article, the historical aspects, the pathophysiology and the clinical manifestations of the disease, will be described.

Conclusions:

It is necessary to recognize Pompe disease because this pathology is treatable.

Keywords : Acid maltase deficiency disease; GAA deficiency; Pompe disease; Type II glycogenosis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )